The Effect of Repetitive Transcranial Magnetic Stimulation on Cognitive Improvement in Dementia With Lewy Bodies

Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age65+
SponsorKorea University Anam Hospital

About this trial

This study aimed to investigate the feasibility of repetitive transcranial magnetic stimulation (rTMS) on the occipital lobe in patients with Lewy body dementia.

This is a proof-of-concept study to evaluate the safety and effect of occipital lobe stimulation in patients with Lewy body dementia. Over a period of two weeks, participants will receive rTMS to the primary visual cortex three times a week during visits. For the remaining 10 weeks, maintenance therapy will be administered with rTMS once a week during visits. Efficacy assessments will be conducted on the day of the final stimulation session and again four weeks later.

Eligibility criteria

Qualifiers

Over 65 years of age

Meeting the criteria for Probable DLB as proposed in the 2017 DLB diagnostic criteria

Scoring between 0.5 and 1 on the Clinical Dementia Rating Scale (CDR)

Disqualifiers

If other causes of cognitive impairment are suspected, such as neurosyphilis, hypothyroidism, hyperthyroidism, metabolic encephalopathy, brain tumor, acute cerebral hemorrhage, acute cerebral infarction, previous territorial or strategic cerebral infarction, Wernicke's encephalopathy, or severe white matter hyperintensity detected in hematological tests, brain MRI, etc.

If cooperation for interviews and self-assessment is difficult (e.g., due to hearing impairment, language disorders, severe psychotic conditions)

If there is a history of psychiatric disorders: major affective disorder, schizophrenia, or schizo-affective disorder

If electroencephalography (EEG) cannot be performed

Trial design

Treatments tested in this trial

  • repetitive transcranial magnetic stimulation

Treatment groups

10 Participants
are divided into 1 treatment group

Sponsors and collaborators